Using nutraceuticals in the management of major depressive disorder (MDD): Approach to be considered for sustainable healthcare systems

Abstract

Purpose

The purpose of this paper is to study evidence-based records on the impact of some effective nutraceuticals on major depression disorder management; and describe the antidepressant properties of nutraceuticals to achieve health policy targets and maintain a sustainable healthcare system.

Design/methodology/approach

The literature was searched using MEDLINE (PubMed), Google Scholar, PsycINFO and Quertile databases and retrieving relevant published articles in peer-reviewed journals.

Findings

The results provided evidence of a range of nutraceuticals with potential benefits in the management of depression. Studies support the anti-depressant properties of S-adenosyl methionine, folnic acid, 5-hydroxytryptophan and omega-3 fatty acids. The results might represent evidence for an innovative adjunctive neurobiological line for the management and treatment of depression.

Practical implications

Randomized-controlled trials and evaluations continue to provide evidence for the use of nutraceuticals in the treatment of depression.

Social implications

Nutraceuticals emphasize the personalized medicine, which offers a psychophysical balance to the individual.

Originality/value

Nutraceuticals have specific antidepressant properties that may be beneficial in psychiatric populations and reduce pharmacotherapeutic side effects.

Citation

Khalifa, N. and Aljaaly, E.A. (2017), "Using nutraceuticals in the management of major depressive disorder (MDD): Approach to be considered for sustainable healthcare systems", World Journal of Science, Technology and Sustainable Development, Vol. 14 No. 1, pp. 50-59. https://doi.org/10.1108/WJSTSD-01-2016-0007